Fisher Scientific International Inc.Fisher Scientific International Inc.
2002 Annual ReportLetter to ShareholdersFisher At A GlanceQ & ALeadershipCorporate Information
Beyond ServiceBeyond BoundariesBeyond FulfillmentBeyond TechnologyFinancialsbacknext


Supplementary Information
Selected Financial Data
MD&A
Statement of Operations
Balance Sheet
Statement Of Cash Flows
Statement Of Changes in Stockholders Equity
Notes
Auditors' Report


CONTROL OF THE COMPANY
As of February 25, 2003, certain affiliates of Thomas H. Lee Company (“THL”) (“THL Entities”), JP Morgan Partners (“JP Morgan”), Merrill Lynch & Co. (“Merrill Lynch”) and Credit Suisse First Boston (USA), Inc. (“CSFB” and, together with the THL Entities, JP Morgan and Merrill Lynch, the “Equity Investors”) owned (on a diluted basis) 19.5 percent of our issued and outstanding common stock, with the THL Entities owning 12.7 percent of such outstanding stock. These Equity Investors and certain members of management entered into an Investor’s Agreement dated January 21, 1998, as amended (the “Investor’s Agreement”). The Investor’s Agreement provides that our Board of Directors will comprise at least nine, but not more than ten directors, four of whom will be appointed by the THL Entities, one of whom will be appointed by DLJ Merchant Banking Partners II, L.P., one of whom will be Paul M. Montrone and one of whom will be Paul M. Meister. Accordingly, the Equity Investors have significant control over us and have the power to elect a majority of our directors. The directors elected pursuant to the Investor’s Agreement will have the authority to make decisions affecting our capital structure, including the issuance of additional capital stock, the implementation of stock repurchase programs and the declaration of dividends, appoint new management and approve any action requiring the approval of the holders of our common stock, including adopting amendments to our certificate of incorporation and approving mergers or sales of substantially all of our assets. There can be no assurance that the interests of the Equity Investors will not conflict with the interests of our other shareholders. Sales or other dispositions of our common stock by the Equity Investors as well as new requirements of the New York Stock Exchange and under the Sarbanes-Oxley Act of 2002 may affect or change the composition of our Board of Directors.

CAUTIONARY FACTORS REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report includes forward-looking statements. All statements other than statements of historical facts included in this Annual Report may constitute forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that our assumptions made in connection with the forward-looking statements are reasonable, there can be no assurances that the assumptions and expectations will prove to have been correct. These forward-looking statements are subject to various risks, uncertainties and assumptions including, among other things:
1.  our outstanding indebtedness and leverage, and the restrictions imposed by our indebtedness;
2.  the effects of domestic and international economic, political and business conditions on our businesses;
3.  the high degree of competition of certain of our businesses, and the potential for new competitors to enter into these businesses;
4.  the extent to which we undertake new acquisitions or enter into strategic joint ventures or partnerships, and the terms of any such acquisition or strategic joint venture or partnership;
5.  future modifications to existing environmental laws and regulations and governmental orders or decrees respecting remediation or clean-up;
6.  discovery of unknown contingent liabilities, including environmental contamination at or emanating from our facilities and liability with respect to products we distribute and manufacture;
7.  fluctuations in interest rates and in foreign currency exchange rates;
8.  availability, or increases in the cost, of raw materials and other inputs used to make our products;
9.  the loss of major customers or suppliers including any provider of shipping services; and
10.  our ability to generate free cash flow or to obtain sufficient resources to finance working capital and capital expenditure needs.
backnext   PAGE 9 of 10